Review Date: 01/11/2025

Renal anaemia or anaemia associated with chemotherapy

Brand: Binocrit, Eprex

Rationale: 1,2,8

NICE TA323 Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy

1.1 Erythropoiesis stimulating agents (epoetin alfa, beta, theta and zeta, and darbepoetin alfa) are recommended, within their marketing authorisations, as options for treating anaemia in people with cancer who are having chemotherapy.

1.2 If different erythropoiesis stimulating agents are equally suitable, the product with the lowest acquisition cost for the course of treatment should be used.